Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, Director, 10% OwnerBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Aug 31, 2023
Net Buying
Open-Market Buys
$11K
Open-Market Sells
$0
Net Open-Market Flow
$11K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2023Buy(P)5K$2.22$11K165K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001021771-23-000086) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML